# PhaseBio Pharmaceuticals Inc. (PHAS)

Source: https://www.quantisnow.com/company/PHAS
Generated: 2026-11-09T21:35:26.911Z

- Ticker: PHAS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2018
- Website: phasebio.com

## About

PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiopulmonary diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or emergency surgery. The company is also developing PB1046, a vasoactive intestinal peptide analogue that is in Phase IIb clinical trial for the treatment of pulmonary arterial hypertension; and PB6440 for the treatment of resistant hypertension. The company has a co-development agreement with SFJ Pharmaceuticals X, Ltd. to develop PB2452, a reversal agent for the antiplatelet drug ticagrelor. PhaseBio Pharmaceuticals, Inc. was incorporated in 2002 and is based in Malvern, Pennsylvania.

## Latest PHAS news and filings

- 2023-11-29 21:55 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-5109417)
- 2023-11-15 21:17 UTC [SEC Form NT 10-Q filed by PhaseBio Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-phasebio-pharmaceuticals-inc-5087764)
- 2023-10-03 11:17 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-4998954)
- 2023-09-27 12:52 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-4989831)
- 2023-08-25 16:34 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-4938488)
- 2023-08-25 16:31 UTC [SEC Form NT 10-Q filed by PhaseBio Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-phasebio-pharmaceuticals-inc-4938476)
- 2023-06-30 20:21 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-4710659)
- 2023-05-30 20:02 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-4576811)
- 2023-05-19 20:18 UTC [SEC Form 4] [SEC Form 4 filed by Van Den Broek Richard](https://www.quantisnow.com/insight/sec-form-4-filed-by-van-den-broek-richard-4533800)
- 2023-05-19 20:18 UTC [SEC Form 4] [SEC Form 4 filed by Thorp Clay](https://www.quantisnow.com/insight/sec-form-4-filed-by-thorp-clay-4533787)
- 2023-05-19 20:18 UTC [SEC Form 4] [SEC Form 4 filed by Humphries William D.](https://www.quantisnow.com/insight/sec-form-4-filed-by-humphries-william-d-4533771)
- 2023-05-19 20:17 UTC [SEC Form 4] [SEC Form 4 filed by Harrigan Edmund](https://www.quantisnow.com/insight/sec-form-4-filed-by-harrigan-edmund-4533766)
- 2023-05-19 20:17 UTC [SEC Form 4] [SEC Form 4 filed by Sapir Alex](https://www.quantisnow.com/insight/sec-form-4-filed-by-sapir-alex-4533754)
- 2023-05-19 20:16 UTC [SEC Form 4] [SEC Form 4 filed by Loewy Caroline M](https://www.quantisnow.com/insight/sec-form-4-filed-by-loewy-caroline-m-4533733)
- 2023-05-19 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Hutson Nancy J](https://www.quantisnow.com/insight/sec-form-4-filed-by-hutson-nancy-j-4533703)
- 2023-05-16 20:23 UTC [SEC Form NT 10-Q filed by PhaseBio Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-phasebio-pharmaceuticals-inc-4515167)
- 2023-05-10 12:08 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-4476152)
- 2023-04-03 20:05 UTC [SEC Form NT 10-K filed by PhaseBio Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-phasebio-pharmaceuticals-inc-4289125)
- 2023-03-24 12:07 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-4244382)
- 2023-02-24 12:59 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-4112645)
- 2023-02-14 21:45 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by PhaseBio Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-phasebio-pharmaceuticals-inc-amendment-4064736)
- 2023-02-14 20:01 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by PhaseBio Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-phasebio-pharmaceuticals-inc-amendment-4061833)
- 2023-02-14 19:26 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by PhaseBio Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-phasebio-pharmaceuticals-inc-amendment-4061336)
- 2023-02-06 20:02 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by PhaseBio Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-phasebio-pharmaceuticals-inc-amendment-4009440)
- 2023-01-25 13:04 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-termination-of-a-3950904)
- 2023-01-17 13:08 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-3916833)
- 2022-12-23 13:33 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-notice-of-delisting-3840542)
- 2022-12-02 21:19 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-3762762)
- 2022-11-23 21:08 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-other-3728026)
- 2022-11-15 21:21 UTC [SEC Form NT 10-Q filed by PhaseBio Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-phasebio-pharmaceuticals-inc-3691823)
- 2022-11-08 22:21 UTC [SEC Form 8-K] [PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Financial Statements and Exhibits](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-3652372)
- 2022-11-04 20:42 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by PhaseBio Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-phasebio-pharmaceuticals-inc-amendment-3636395)
- 2022-11-04 14:26 UTC [Market Insight] [Short Volatility Alert: PhaseBio Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/short-volatility-alert-phasebio-pharmaceuticals-inc-3633638)
- 2022-11-03 09:40 UTC [Market Insight] [Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday](https://www.quantisnow.com/insight/why-tupperware-brands-shares-dipped-around-42-here-are-89-3621962)
- 2022-11-02 17:28 UTC [Market Insight] [Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-benefitfocus-shares-are-trading-higher-by-around-48-here-3617989)
- 2022-11-02 12:20 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-pre-market-session-3615451)
- 2022-11-02 11:58 UTC [Market Insight] [Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-rogers-shares-are-trading-sharply-lower-here-are-33-3615021)
- 2022-11-01 18:33 UTC [Market Chatter] [PhaseBio Pharmaceuticals shares are trading lower after the company reported it received notice from Nasdaq stating it has determined that the company's securities will be delisted from Nasdaq.](https://www.quantisnow.com/insight/phasebio-pharmaceuticals-shares-are-trading-lower-after-the-company-reported-3610688)
- 2022-11-01 18:10 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-intraday-session-3610532)
- 2022-11-01 15:48 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Tuesday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-tuesday-3609710)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/PHAS
- Earnings history: https://www.quantisnow.com/earnings/PHAS
- Dividend history: https://www.quantisnow.com/dividends/PHAS
- Insider transactions: https://www.quantisnow.com/insiders/PHAS
- Options chain: https://www.quantisnow.com/options/PHAS
- SEC 8-K filings only: https://www.quantisnow.com/company/PHAS/8-k
- RSS and alerts for PHAS: https://www.quantisnow.com/docs/rss-feeds.md